|
|||||
|
Pfizer exec Martin Mackay is decamping for cross-Atlantic rival AstraZeneca, where he’ll be president of R&D, a new position, Dow Jones Newswires reports. Mackay held the same title at Pfizer from 2007 to 2009, but in the wake of the company’s Wyeth acquisition, he split the top job … The company held its annual meeting at the Bank of America Auditorium in Boston, but told a Dow Jones Newswires reporter that media weren’t allowed to attend.
Dow Jones tops 11000 « Dominic Stoughton’s Blog
The Dow Jones industrial average closed the week up 70.28 points, or 0.6 percent, at 10997.35. The Standard & Poor’s 500 index rose 16.27, or 1.4 percent, to 1194.37. The Nasdaq composite index rose 51.47, or 2.1 percent, to 2454.05. Read this article:Dow Jones tops 11000 « Dominic [...] The FDA today disclosed several warning letters it had sent to drug makers and weight-loss spas for “false” and-or “misleading” claims for their products. Here’s a rundown: Biogen Idec was cited for a promotional Webcast involving the multiple sclerosis drug Tysabri because it minimized the risk of a serious brain infection, the FDA said. The [...] The FDA posted documents today saying the effectiveness of Forest Laboratories’ experimental lung drug Daxas was “quite modest” while expressing concern about side effects seen in clinical trials. In particular, the FDA staff cited three suicides and two suicide attempts among patients using the drug who were studied. Here’s the Dow Jones article. Despite the low efficacy [...] GlaxoSmithKline finally got some good news from a study of its diabetes drug Avandia, but some top leading cardiologists remain unconvinced, saying the company’s new research has serious flaws. The results, unveiled late this afternoon at the American Diabetes Association conference in New Orleans, found Avandia doesn’t increase patients’ risk for heart attacks, according [...] Powerful antipsychotics currently used to treat adults for schizophrenia and bipolar disorder appear to be effective in treating children and teens as well, though there are serious risks associated with the medicines, according to documents put out by the FDA staff today. AstraZeneca’s Seroquel, Eli Lilly’s Zyprexa and Pfizer’s Geodon are all being considered by the [...] In a setback to its pipeline restocking efforts, Merck said this morning that a developmental drug to treat acute heart failure had failed in a late-stage clinical trial. As a result of missing the primary and secondary endpoints, the company won’t file for regulatory approval of rolofylline this year but will continue to analyze the [...] It’s been more than a year since we wrote about the shortage of nuclear isotopes used in medical imaging that followed the shutdown of a Canadian reactor. Now the reactor (pictured) is down again, and the shortage is back. “It’s sort of medium-bad at this point, but it looks like it’s going to get a whole [...] A few highlights out of ASCO, the big cancer conference on in Orlando this weekend: Roche’s breast-cancer drug Herceptin extended the lives of some patients with stomach cancer. The drug is used in people whose tumors produce excessive amounts of a protein called her-2. That occurs in about 20%-25% of breast cancer and stomach cancer cases. [...] |
|||||
|
217 queries. 0.500 seconds. |
|||||